Exposure to topiramate may not increase the risk of urolithiasis: A nationwide cohort study
Epilepsy & Behavior Reports · 2026-06 · 34 · 100864
DOI: 10.1016/j.ebr.2026.100864 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Epilepsy & Behavior Reports, 2026-06. Verfasst von Kimoon Chang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Uijeongbu, the Republic of Korea. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Yonsei University College of Medicine.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Uijeongbu, the Republic of Korea.
- Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, the Republic of Korea.
Förderung
- Yonsei University College of Medicine
Zitieren
APA
Chang, K., & Ha, W. S. (2026). Exposure to topiramate may not increase the risk of urolithiasis: A nationwide cohort study. Epilepsy & Behavior Reports, 34, 100864. https://doi.org/10.1016/j.ebr.2026.100864
Vancouver
Chang K, Ha WS. Exposure to topiramate may not increase the risk of urolithiasis: A nationwide cohort study. Epilepsy & Behavior Reports. 2026;34:100864. doi:10.1016/j.ebr.2026.100864
BibTeX
@article{Chang2026,
author = {Chang, Kimoon and Ha, Woo-Seok},
title = {Exposure to topiramate may not increase the risk of urolithiasis: A nationwide cohort study},
journal = {Epilepsy & Behavior Reports},
year = {2026},
volume = {34},
pages = {100864},
doi = {10.1016/j.ebr.2026.100864}
}
EUVIMED